Melanoma in situ of the right lower eyelid, including the canthus, is a localized skin cancer characterized by the uncontrolled growth of melanocytes. This condition is significant due to its potential for progression to invasive melanoma if left untreated. Accurate coding with ICD-10 Code D03.112 facilitates precise diagnosis, documentation, medical billing, and public health reporting, ensuring appropriate patient management and resource allocation.
ICD-10 Code D03.112 specifically denotes melanoma in situ located on the right lower eyelid, including the canthus. This code is utilized when documenting cases of melanoma that have not invaded deeper tissues, allowing for targeted treatment and monitoring. It is essential for accurate clinical documentation and billing, particularly in dermatology and oncology settings.
Melanoma in situ of the right lower eyelid, including canthus, arises from the proliferation of atypical melanocytes confined to the epidermis. This condition is primarily caused by ultraviolet (UV) radiation exposure and may progress to invasive melanoma if not addressed promptly. Medical attention is crucial for early detection and intervention.
ICD-10 Code D03.112 is integral to SOAP notes, facilitating the documentation of patient symptoms, clinical assessments, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient records and appropriate billing practices.
In SOAP notes, ICD-10 Code D03.112 connects subjective patient reports and objective clinical findings to a formal diagnosis of melanoma in situ. This code supports continuity of care, aids in billing processes, and ensures compliance with EHR documentation standards.
Prompt treatment of melanoma in situ is essential to prevent progression. Surgical excision is the primary treatment modality.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D03.112 is crucial for accurate billing in hospital, ER, or outpatient settings, ensuring proper reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 11400 | Excision, benign skin lesion, excised diameter up to 1.0 cm. |
| 11600 | Excision, malignant skin lesion, excised diameter up to 1.0 cm. |
| 99213 | Established patient office visit, level 3. |
| 17000 | Destruction of premalignant skin lesions. |
Common Questions About Using ICD-10 Code D03.112 for Melanoma in situ of right lower eyelid, including canthus
What are the risk factors for developing melanoma in situ?
Risk factors include excessive sun exposure, a history of sunburns, having multiple moles or atypical moles, and a family history of skin cancer. Regular skin checks are essential for early detection.
How is melanoma in situ treated?
The primary treatment for melanoma in situ is surgical excision of the lesion with clear margins. Follow-up care is crucial to monitor for any recurrence.
Is melanoma in situ contagious?
No, melanoma in situ is not contagious. It is a type of skin cancer that arises from the skin's melanocytes and is not spread from person to person.
What is the prognosis for melanoma in situ?
The prognosis for melanoma in situ is generally excellent when detected early and treated appropriately. The risk of progression to invasive melanoma is significantly reduced with timely intervention.
Clinical Notes
SOAP notes
DAP notes
AI medical notes